-
2
-
-
0025910589
-
-
Bordeaux 1991 {published data only} *Mauriac L, Durand M, Avril A, Dilhuydy JM. Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumors larger than 3 cm. Results of a randomized trial in a single centre. Annals of Oncology 1991;2(5):347-54.
-
Bordeaux 1991 {published data only} *Mauriac L, Durand M, Avril A, Dilhuydy JM. Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumors larger than 3 cm. Results of a randomized trial in a single centre. Annals of Oncology 1991;2(5):347-54.
-
-
-
-
3
-
-
0033058219
-
Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: A unicentre randomized trial with a 124-month median follow-up. Institut Bergonie Bordeaux Groupe Sein (IBBGS)
-
Mauriac L, MacGrogan G, Avril A, Durand M, Floquet A, Debled M, et al.Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: a unicentre randomized trial with a 124-month median follow-up. Institut Bergonie Bordeaux Groupe Sein (IBBGS). Annals of Oncology 1999;10(1):47-52.
-
(1999)
Annals of Oncology
, vol.10
, Issue.1
, pp. 47-52
-
-
Mauriac, L.1
MacGrogan, G.2
Avril, A.3
Durand, M.4
Floquet, A.5
Debled, M.6
-
4
-
-
44949175149
-
-
ECTO 2005 {published data only} Eiermann W, Sabadell D, Baselga J, Vazquez V, Guillem Porta V, Semiglazov V, et al.European cooperative trial in operable breast cancer (ECTO): No increased risk of local breast tumor recurrence (LBR) as first and only event after primary systemic therapy (PST). American Society of Clinical Oncology. 2003; 22:Abstract 37.
-
ECTO 2005 {published data only} Eiermann W, Sabadell D, Baselga J, Vazquez V, Guillem Porta V, Semiglazov V, et al.European cooperative trial in operable breast cancer (ECTO): No increased risk of local breast tumor recurrence (LBR) as first and only event after primary systemic therapy (PST). American Society of Clinical Oncology. 2003; Vol. 22:Abstract 37.
-
-
-
-
5
-
-
29244467646
-
European cooperative trial in operable breast cancer (ECTO): Improved freedom from progression (FFP) from adding paclitaxel (T) to doxorubicin (A) followed by cyclophosphamide methotrexate and fluorouracil (CMF)
-
Abstract 513
-
*Gianni L, Baselga J, Eiermann W, Guillem Porta V, Semiglazov V, Lluch A, et al.European cooperative trial in operable breast cancer (ECTO): Improved freedom from progression (FFP) from adding paclitaxel (T) to doxorubicin (A) followed by cyclophosphamide methotrexate and fluorouracil (CMF). Journal of Clinical Oncology, ASCO Annual Meeting Proceedings 2005;23(Suppl 16):Abstract 513.
-
(2005)
Journal of Clinical Oncology, ASCO Annual Meeting Proceedings
, vol.23
, Issue.SUPPL. 16
-
-
*Gianni, L.1
Baselga, J.2
Eiermann, W.3
Guillem Porta, V.4
Semiglazov, V.5
Lluch, A.6
-
6
-
-
0028799631
-
-
Edinburgh 1995 {published data only} Forouhi P, Dixon JM, Leonard RC, Chetty U. Prospective randomized study of surgical morbidity following primary systemic therapy for breast cancer. British Journal of Surgery 1995;82(1):79-82.
-
Edinburgh 1995 {published data only} Forouhi P, Dixon JM, Leonard RC, Chetty U. Prospective randomized study of surgical morbidity following primary systemic therapy for breast cancer. British Journal of Surgery 1995;82(1):79-82.
-
-
-
-
7
-
-
0035890633
-
-
EORTC 2001 {published and unpublished data} *van der Hage JA, van de Velde CJ, Julien JP, Tubiana-Hulin M, Vandervelden C, Duchateau L. Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902. Journal of Clinical Oncology 2001;19(22):4224-37.
-
EORTC 2001 {published and unpublished data} *van der Hage JA, van de Velde CJ, Julien JP, Tubiana-Hulin M, Vandervelden C, Duchateau L. Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902. Journal of Clinical Oncology 2001;19(22):4224-37.
-
-
-
-
8
-
-
0026316516
-
-
Institut Curie 1991 {published data only} Scholl SM, Asselain B, Palangie T, Dorval T, Jouve M, Garcia Giral E, et al.Neoadjuvant chemotherapy in operable breast cancer. European Journal of Cancer 1991;27(12):1668-71.
-
Institut Curie 1991 {published data only} Scholl SM, Asselain B, Palangie T, Dorval T, Jouve M, Garcia Giral E, et al.Neoadjuvant chemotherapy in operable breast cancer. European Journal of Cancer 1991;27(12):1668-71.
-
-
-
-
9
-
-
0033428140
-
-
Institut Curie 1994 {published data only} Broet P, Scholl SM, de la Rochefordiere A, Fourquet A, Moreau T, De Rycke Y, et al.Short and long-term effects on survival in breast cancer patients treated by primary chemotherapy: an updated analysis of a randomized trial. Breast Cancer Res Treat 1999;58(2):151-56.
-
Institut Curie 1994 {published data only} Broet P, Scholl SM, de la Rochefordiere A, Fourquet A, Moreau T, De Rycke Y, et al.Short and long-term effects on survival in breast cancer patients treated by primary chemotherapy: an updated analysis of a randomized trial. Breast Cancer Res Treat 1999;58(2):151-56.
-
-
-
-
10
-
-
0028357653
-
Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: Preliminary results of a randomised trial: S6
-
*Scholl SM, Fourquet A, Asselain B, Pierga JY, Vilcoq JR, Durand JC, et al.Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: preliminary results of a randomised trial: S6. European Journal of Cancer 1994;30A(5):645-52.
-
(1994)
European Journal of Cancer
, vol.30 A
, Issue.5
, pp. 645-652
-
-
*Scholl, S.M.1
Fourquet, A.2
Asselain, B.3
Pierga, J.Y.4
Vilcoq, J.R.5
Durand, J.C.6
-
11
-
-
0029584199
-
Breast tumour response to primary chemotherapy predicts local and distant control as well as survival
-
Scholl SM, Pierga JY, Asselain B, Beuzeboc P, Dorval T, Garcia-Giralt E, et al.Breast tumour response to primary chemotherapy predicts local and distant control as well as survival. European Journal of Cancer 1995;31A(12):1969-75.
-
(1995)
European Journal of Cancer
, vol.31 A
, Issue.12
, pp. 1969-1975
-
-
Scholl, S.M.1
Pierga, J.Y.2
Asselain, B.3
Beuzeboc, P.4
Dorval, T.5
Garcia-Giralt, E.6
-
12
-
-
44949168732
-
-
Japan 1998 {published and unpublished data} Enomoto K, Ikeda T, Matsui A, Kitajima M, Koh J, Masamura S, et al.Neoadjuvant therapy in stage II with T>=4CM and stage III breast cancer. 6th International Conference Adjuvant therapy for Primary Breast Cancer St Gallen. 1998:P73.
-
Japan 1998 {published and unpublished data} Enomoto K, Ikeda T, Matsui A, Kitajima M, Koh J, Masamura S, et al.Neoadjuvant therapy in stage II with T>=4CM and stage III breast cancer. 6th International Conference Adjuvant therapy for Primary Breast Cancer St Gallen. 1998:P73.
-
-
-
-
13
-
-
44949139797
-
-
Lithuania 1998 {published data only} Ostapenko V, Pipiriene T, Valuckas K. Primary chemotherapy in conservative treatment of stage II breast cancer. In 6th International Conference Adjuvant therapy for Primary Breast Cancer St Gallen. 1998:Abstract P78.
-
Lithuania 1998 {published data only} Ostapenko V, Pipiriene T, Valuckas K. Primary chemotherapy in conservative treatment of stage II breast cancer. In 6th International Conference Adjuvant therapy for Primary Breast Cancer St Gallen. 1998:Abstract P78.
-
-
-
-
14
-
-
0034994441
-
-
London 2001 {published data only} Gazet JC, Ford HT, Gray R, McConkey C, Sutcliffe R, Quilliam J, et al.Estrogen-receptor-directed neoadjuvant therapy for breast cancer: results of a randomised trial using formestane and methotrexate, mitozantrone and mitomycin C (MMM) chemotherapy. Annals of Oncology 2001;12(5):685-91.
-
London 2001 {published data only} Gazet JC, Ford HT, Gray R, McConkey C, Sutcliffe R, Quilliam J, et al.Estrogen-receptor-directed neoadjuvant therapy for breast cancer: results of a randomised trial using formestane and methotrexate, mitozantrone and mitomycin C (MMM) chemotherapy. Annals of Oncology 2001;12(5):685-91.
-
-
-
-
15
-
-
0031926839
-
-
NSABP 1998 {published data only} *Fisher B, Bryant J, Wolmark N, Mamounas E, Brown A, Fisher ER, et al.Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. Journal of Clinical Oncology 1998;16(8):2672-85.
-
NSABP 1998 {published data only} *Fisher B, Bryant J, Wolmark N, Mamounas E, Brown A, Fisher ER, et al.Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. Journal of Clinical Oncology 1998;16(8):2672-85.
-
-
-
-
16
-
-
0035751675
-
Preoperative chemotherapy in patients with operable breast cancer: Nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18
-
Wolmark N, Wang J, Mamounas E, Bryant J, Fisher B. Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18. Journal of the National Cancer Institute. Monographs 2001;30:96-102.
-
(2001)
Journal of the National Cancer Institute. Monographs
, vol.30
, pp. 96-102
-
-
Wolmark, N.1
Wang, J.2
Mamounas, E.3
Bryant, J.4
Fisher, B.5
-
17
-
-
14644394275
-
-
Royal Marsden 1998 {published data only} Cleator SJ, Makris A, Ashley SE, Lal R, Powles TJ. Good clinical response of breast cancers to adjuvant chemoendocrine therapy is associated with improved overall survival. Annals of Oncology 2005;16:267-72.
-
Royal Marsden 1998 {published data only} Cleator SJ, Makris A, Ashley SE, Lal R, Powles TJ. Good clinical response of breast cancers to adjuvant chemoendocrine therapy is associated with improved overall survival. Annals of Oncology 2005;16:267-72.
-
-
-
-
18
-
-
0031743702
-
A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer
-
*Makris A, Powles TJ, Ashley SE, Chang J, Hickish T, Tidy VA, Nash AG, Ford HT. A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer. Annals of Oncology 1998;9(11):1179-84.
-
(1998)
Annals of Oncology
, vol.9
, Issue.11
, pp. 1179-1184
-
-
*Makris, A.1
Powles, T.J.2
Ashley, S.E.3
Chang, J.4
Hickish, T.5
Tidy, V.A.6
Nash, A.G.7
Ford, H.T.8
-
19
-
-
0028048459
-
-
St. Petersburg 1994 {published data only} Semiglazov VF, Topuzov EE, Bavli JL, Moiseyenko VM, Ivanova OA, Seleznev IK, et al.Primary (neoadjuvant) chemotherapy and radiotherapy compared with primary radiotherapy alone in stage IIb-IIIa breast cancer. Annals of Oncology 1994;5(7):591-5.
-
St. Petersburg 1994 {published data only} Semiglazov VF, Topuzov EE, Bavli JL, Moiseyenko VM, Ivanova OA, Seleznev IK, et al.Primary (neoadjuvant) chemotherapy and radiotherapy compared with primary radiotherapy alone in stage IIb-IIIa breast cancer. Annals of Oncology 1994;5(7):591-5.
-
-
-
-
20
-
-
0141907188
-
-
USA 2003 {published data only} Danforth DN Jr, Cowan K, Altemus R, Merino M, Chow C, Berman A, et al.Preoperative FLAC/granulocyte- colony-stimulating factor chemotherapy for stage II breast cancer: a prospective randomized trial. Annals of Surgical Oncology 2003;10(6):635-44.
-
USA 2003 {published data only} Danforth DN Jr, Cowan K, Altemus R, Merino M, Chow C, Berman A, et al.Preoperative FLAC/granulocyte- colony-stimulating factor chemotherapy for stage II breast cancer: a prospective randomized trial. Annals of Surgical Oncology 2003;10(6):635-44.
-
-
-
-
21
-
-
0345306607
-
-
Deo 2003 Deo SV, Bhutani M, Shukla NK, Raina V, Rath GK, Purkayasth J. Randomized trial comparing neo-adjuvant versus adjuvant chemotherapy in operable locally advanced breast cancer (T4b N0-2 M0). Journal of Surgical Oncology 2003;84(4):192-7.
-
Deo 2003 Deo SV, Bhutani M, Shukla NK, Raina V, Rath GK, Purkayasth J. Randomized trial comparing neo-adjuvant versus adjuvant chemotherapy in operable locally advanced breast cancer (T4b N0-2 M0). Journal of Surgical Oncology 2003;84(4):192-7.
-
-
-
-
22
-
-
44949194942
-
-
Hyams 1993 Hyams DM, Fieler MA, Nobis G. An institutional experience with preoperative systematic chemotherapy in early stage breast cancer. Breast Cancer Research & Treatment 1993;27(1/2):147 (Abstract 68).
-
Hyams 1993 Hyams DM, Fieler MA, Nobis G. An institutional experience with preoperative systematic chemotherapy in early stage breast cancer. Breast Cancer Research & Treatment 1993;27(1/2):147 (Abstract 68).
-
-
-
-
23
-
-
44949261167
-
-
Ragaz 1997 Ragaz J, Baird R, Rebbeck P, Trevisan C, Goldie J, Coldman A. Preoperative (neoadjuvant - PRE) versus postoperative (POST) adjuvant chemotherapy (CT) for stage i-II breast cacner (SI-II BC). Long-term analysis of British Columbia randomized trial. American Society of Clinical Oncology. Annual Meeting. 1997:Abstract 499.
-
Ragaz 1997 Ragaz J, Baird R, Rebbeck P, Trevisan C, Goldie J, Coldman A. Preoperative (neoadjuvant - PRE) versus postoperative (POST) adjuvant chemotherapy (CT) for stage i-II breast cacner (SI-II BC). Long-term analysis of British Columbia randomized trial. American Society of Clinical Oncology. Annual Meeting. 1997:Abstract 499.
-
-
-
-
24
-
-
0032925171
-
-
Shao 1999 Shao ZM, Li J, Wu J, Han QX, Shen ZZ, Fontana JA, et al.Neoadjuvant chemotherapy for operable breast cancer induces apoptosis. Breast Cancer Research and Treatment 1999;53(3):263-9.
-
Shao 1999 Shao ZM, Li J, Wu J, Han QX, Shen ZZ, Fontana JA, et al.Neoadjuvant chemotherapy for operable breast cancer induces apoptosis. Breast Cancer Research and Treatment 1999;53(3):263-9.
-
-
-
-
25
-
-
44949159002
-
-
Stauffer 1993 Stauffer JS, Allred DC, Aust JB, Cruz AB. Preoperative versus postoperative adjuvant chemotherapy in early operable breast cancer. Breast Cancer Research & Treatment 1993;27(1/2):148 (Abstract 148).
-
Stauffer 1993 Stauffer JS, Allred DC, Aust JB, Cruz AB. Preoperative versus postoperative adjuvant chemotherapy in early operable breast cancer. Breast Cancer Research & Treatment 1993;27(1/2):148 (Abstract 148).
-
-
-
-
26
-
-
8944233855
-
-
Abraham 1996 Abraham DC, Jones RC, Jones SE, Cheek JH, Peters GN, Knox SM, et al.Evaluation of neoadjuvant chemotherapeutic response of locally advanced breast cancer bymagnetic resonance imaging. Cancer 1996;78(1):91-100.
-
Abraham 1996 Abraham DC, Jones RC, Jones SE, Cheek JH, Peters GN, Knox SM, et al.Evaluation of neoadjuvant chemotherapeutic response of locally advanced breast cancer bymagnetic resonance imaging. Cancer 1996;78(1):91-100.
-
-
-
-
27
-
-
0344393609
-
-
Arriagada 2003 Arriagada R, Le MG, Guinebretiere JM, Dunant A, Rochard F, Tursz T. Late local recurrences in a randomised trial comparing conservative treatment with total mastectomy in early breast cancer patients. Annals Of Oncology 2003;14(11):1617-22. [MEDLINE: 103].
-
Arriagada 2003 Arriagada R, Le MG, Guinebretiere JM, Dunant A, Rochard F, Tursz T. Late local recurrences in a randomised trial comparing conservative treatment with total mastectomy in early breast cancer patients. Annals Of Oncology 2003;14(11):1617-22. [MEDLINE: 103].
-
-
-
-
28
-
-
2942729848
-
-
Ayers 2004 Ayers M, Symmans WF, Stec J, Damokosh AI, Clark E, Hess K, et al.Gene expression profiles predict complete pathologic response to neoadjuvant paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide chemotherapy in breast cancer. J Clin Oncol 2004;22(12):2284-93.
-
Ayers 2004 Ayers M, Symmans WF, Stec J, Damokosh AI, Clark E, Hess K, et al.Gene expression profiles predict complete pathologic response to neoadjuvant paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide chemotherapy in breast cancer. J Clin Oncol 2004;22(12):2284-93.
-
-
-
-
29
-
-
33646445341
-
-
Bear 2006 Bear HD, Anderson S, Smith RE, Geyer CE, Jr, Mamounas EP, Fisher B, et al.Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer:National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol 2006;24(13):2019-27.
-
Bear 2006 Bear HD, Anderson S, Smith RE, Geyer CE, Jr, Mamounas EP, Fisher B, et al.Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer:National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol 2006;24(13):2019-27.
-
-
-
-
30
-
-
0026466303
-
-
Blichert-Toft 1992 Blichert-Toft M, Rose C, Andersen JA, Overgaard M, Axelsson CK, Andersen KW, et al.Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. Danish Breast Cancer Cooperative Group. Journal National Cancer Institute Monographs 1992;11:19-25.
-
Blichert-Toft 1992 Blichert-Toft M, Rose C, Andersen JA, Overgaard M, Axelsson CK, Andersen KW, et al.Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. Danish Breast Cancer Cooperative Group. Journal National Cancer Institute Monographs 1992;11:19-25.
-
-
-
-
31
-
-
0024987463
-
-
Bonadonna 1990 Bonadonna G, Veronesi U, Brambilla C, Ferrari L, Luini A, Greco M, et al.Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters ormore. Journal of the National Cancer Institute 1990;82(19):1539-45.
-
Bonadonna 1990 Bonadonna G, Veronesi U, Brambilla C, Ferrari L, Luini A, Greco M, et al.Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters ormore. Journal of the National Cancer Institute 1990;82(19):1539-45.
-
-
-
-
32
-
-
0028909867
-
-
Bonadonna 1995 Bonadonna G, Valagussa P, Moliterni A, Zambetti M, Brambilla C. Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer: The results of 20 years of follow-up. New England Journal of Medicine 1995;332:901-6.
-
Bonadonna 1995 Bonadonna G, Valagussa P, Moliterni A, Zambetti M, Brambilla C. Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer: The results of 20 years of follow-up. New England Journal of Medicine 1995;332:901-6.
-
-
-
-
33
-
-
20544460650
-
-
Buzdar 2005 Buzdar AU, Ibrahim NK, Francis D, Booser DJ, Thomas ES, Theriault RL, et al.Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer. Journal of Clinical Oncology 2005;23(16):3676-85.
-
Buzdar 2005 Buzdar AU, Ibrahim NK, Francis D, Booser DJ, Thomas ES, Theriault RL, et al.Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer. Journal of Clinical Oncology 2005;23(16):3676-85.
-
-
-
-
34
-
-
0042125511
-
-
Chang 2003 Chang JC, Wooten EC, Tsimelzon A, Hilsenbeck SG, Gutierrez MC, Elledge R, et al.Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer. Lancet 2003;362(9381):362-9.
-
Chang 2003 Chang JC, Wooten EC, Tsimelzon A, Hilsenbeck SG, Gutierrez MC, Elledge R, et al.Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer. Lancet 2003;362(9381):362-9.
-
-
-
-
35
-
-
24044515003
-
-
Chua 2005 Chua S, Smith IE, A'Hern RP, Coombes GA, Hickish TF, Robinson AC, et al.Neoadjuvant vinorelbine/epirubicin (VE) versus standard adriamycin/cyclophosphamide (AC) in operable breast cancer: analysis of response and tolerability in a randomised phase III trial (TOPIC 2). Annals of Oncology 2005;16(9):1435-41.
-
Chua 2005 Chua S, Smith IE, A'Hern RP, Coombes GA, Hickish TF, Robinson AC, et al.Neoadjuvant vinorelbine/epirubicin (VE) versus standard adriamycin/cyclophosphamide (AC) in operable breast cancer: analysis of response and tolerability in a randomised phase III trial (TOPIC 2). Annals of Oncology 2005;16(9):1435-41.
-
-
-
-
36
-
-
29144475553
-
-
Clarke 2005 Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans E, et al.Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005;366(9503):2087- 2106.
-
Clarke 2005 Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans E, et al.Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005;366(9503):2087- 2106.
-
-
-
-
37
-
-
44949180004
-
-
Deeks 2001 Deeks JJ, Altman DG, Bradburn MJ. Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In: EggerM, Davey SmithG, AltmanDG editor(s). Systematic Reviews in Health Care: Meta-Analysis in Context. 2nd Edition. London: BMJ Publication Group, 2001.
-
Deeks 2001 Deeks JJ, Altman DG, Bradburn MJ. Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In: EggerM, Davey SmithG, AltmanDG editor(s). Systematic Reviews in Health Care: Meta-Analysis in Context. 2nd Edition. London: BMJ Publication Group, 2001.
-
-
-
-
38
-
-
19344364880
-
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials
-
EBCTCG 2005 Early Breast Cancer Trialists' Collaborative Group
-
EBCTCG 2005 Early Breast Cancer Trialists' Collaborative Group. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005;365(9472):1687-1717.
-
(2005)
Lancet
, vol.365
, Issue.9472
, pp. 1687-1717
-
-
-
39
-
-
0030922816
-
-
Egger 1997 Egger M, Davey SG, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315(7109):629-34. [MEDLINE: 4].
-
Egger 1997 Egger M, Davey SG, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315(7109):629-34. [MEDLINE: 4].
-
-
-
-
40
-
-
0031923428
-
-
Elkhuizen 1998 Elkhuizen PH, van de Vijver MJ, Hermans J, Zonderland HM, van de Velde CJ, Leer JW. Local recurrence after breast-conserving therapy for invasive breast cancer: high incidence in young patients and association with poor survival. International Journal of Radiation Oncology Biology Physics 1998;40(4):859-67. [MEDLINE: 105].
-
Elkhuizen 1998 Elkhuizen PH, van de Vijver MJ, Hermans J, Zonderland HM, van de Velde CJ, Leer JW. Local recurrence after breast-conserving therapy for invasive breast cancer: high incidence in young patients and association with poor survival. International Journal of Radiation Oncology Biology Physics 1998;40(4):859-67. [MEDLINE: 105].
-
-
-
-
41
-
-
21144439271
-
-
Evans 2005 Evans TR, Yellowlees A, Foster E, Earl H, Cameron DA, Hutcheon AW, et al.Phase III randomized trial of doxorubicin and docetaxel versus doxorubicin and cyclophosphamide as primary medical therapy in women with breast cancer: an anglo-celtic cooperative oncology group study. Journal of Clinical Oncology 2005;23(13):2988-2995.
-
Evans 2005 Evans TR, Yellowlees A, Foster E, Earl H, Cameron DA, Hutcheon AW, et al.Phase III randomized trial of doxorubicin and docetaxel versus doxorubicin and cyclophosphamide as primary medical therapy in women with breast cancer: an anglo-celtic cooperative oncology group study. Journal of Clinical Oncology 2005;23(13):2988-2995.
-
-
-
-
42
-
-
44949206709
-
-
Felici 2005 Felici A, Bria E, Ferretti G, Carlini P, Ciccarese M, Cecere FL, et al.Taxanes as neoadjuvant chemotherapy for breast cancer: Pooled-analysis of 3120 patients enrolled in 10 randomized trials. J Clin Oncol ASCO Annual Meeting Proceedings 2005;16S:682.
-
Felici 2005 Felici A, Bria E, Ferretti G, Carlini P, Ciccarese M, Cecere FL, et al.Taxanes as neoadjuvant chemotherapy for breast cancer: Pooled-analysis of 3120 patients enrolled in 10 randomized trials. J Clin Oncol ASCO Annual Meeting Proceedings 2005;16S:682.
-
-
-
-
43
-
-
44949186704
-
-
Ferlay 2001 Ferlay J, Bray F, Pisani P, Parkin DM. Cancer Incidence, Mortality and Prevalence Worldwide. GLOBOCAN, Version 1.0. IARC CancerBase No. 5. Lyon, IARCPress 2001
-
Ferlay 2001 Ferlay J, Bray F, Pisani P, Parkin DM. Cancer Incidence, Mortality and Prevalence Worldwide. GLOBOCAN, Version 1.0. IARC CancerBase No. 5. Lyon, IARCPress 2001.
-
-
-
-
44
-
-
0024544051
-
-
Fisher 1989 Fisher B, Redmond C, Dimitrov NV, Bowman D, Legault-Poisson S, Wickerham DL, et al.A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node-negative breast cancer who have estrogen-receptor-negative tumors. New England Journal of Medicine 1989;320:473-8.
-
Fisher 1989 Fisher B, Redmond C, Dimitrov NV, Bowman D, Legault-Poisson S, Wickerham DL, et al.A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node-negative breast cancer who have estrogen-receptor-negative tumors. New England Journal of Medicine 1989;320:473-8.
-
-
-
-
45
-
-
0028966867
-
-
Fisher 1995 Fisher B, Mamounas EP. Preoperative chemotherapy: a model for studying the biology and therapy of primary breast cancer. J Clin Oncol 1995;13(3):537-540.
-
Fisher 1995 Fisher B, Mamounas EP. Preoperative chemotherapy: a model for studying the biology and therapy of primary breast cancer. J Clin Oncol 1995;13(3):537-540.
-
-
-
-
46
-
-
0037158614
-
-
Fisher 2002 Fisher B, Jeong JH, Anderson S, Bryant J, Fisher ER, Wolmark N. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. The New England Journal Of Medicine 2002;347(8):567-575.
-
Fisher 2002 Fisher B, Jeong JH, Anderson S, Bryant J, Fisher ER, Wolmark N. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. The New England Journal Of Medicine 2002;347(8):567-575.
-
-
-
-
47
-
-
0036710434
-
-
Fredriksson 2002 Fredriksson I, Liljegren G, Arnesson L-G, Emdin SO, Palm-Sjovall M, Fornander T, et al.Local recurrence in the breast after conservative surgery - a study of prognosis and prognostic factors in 391 women. European Journal of Cancer 2002;38(14):1860-1870.
-
Fredriksson 2002 Fredriksson I, Liljegren G, Arnesson L-G, Emdin SO, Palm-Sjovall M, Fornander T, et al.Local recurrence in the breast after conservative surgery - a study of prognosis and prognostic factors in 391 women. European Journal of Cancer 2002;38(14):1860-1870.
-
-
-
-
48
-
-
0141518226
-
-
Fredriksson 2003 Fredriksson I, Liljegren G, Palm-Sjovall M, Arnesson LG, Emdin SO, Fornander T, et al.Risk factors for local recurrence after breast-conserving surgery. Br J Surg 2003;90(9):1093-1102.
-
Fredriksson 2003 Fredriksson I, Liljegren G, Palm-Sjovall M, Arnesson LG, Emdin SO, Fornander T, et al.Risk factors for local recurrence after breast-conserving surgery. Br J Surg 2003;90(9):1093-1102.
-
-
-
-
49
-
-
0037453905
-
-
Goodwin 2003 Goodwin PJ, Black JT, Bordeleau LJ, Ganz PA. Health-related quality-of-life measurement in randomized clinical trials in breast cancer-taking stock. JNCI Cancer Spectrum 2003;95(4):263- 281. [MEDLINE: 6].
-
Goodwin 2003 Goodwin PJ, Black JT, Bordeleau LJ, Ganz PA. Health-related quality-of-life measurement in randomized clinical trials in breast cancer-taking stock. JNCI Cancer Spectrum 2003;95(4):263- 281. [MEDLINE: 6].
-
-
-
-
50
-
-
44949114384
-
-
Haagensen 1943a Haagensen CD, Stout AP. Carcinoma of the breast. Criteria of inoperability. The American surgeon 1943;118:859-66.
-
Haagensen 1943a Haagensen CD, Stout AP. Carcinoma of the breast. Criteria of inoperability. The American surgeon 1943;118:859-66.
-
-
-
-
51
-
-
44949176638
-
-
Haagensen 1943b Haagensen CD, Stout AP. Carcinoma of the breast. Criteria of inoperability. The American surgeon 1943;118:1032-40.
-
Haagensen 1943b Haagensen CD, Stout AP. Carcinoma of the breast. Criteria of inoperability. The American surgeon 1943;118:1032-40.
-
-
-
-
52
-
-
20644447122
-
-
Hannemann 2005 Hannemann J, Oosterkamp HM, Bosch CA, Velds A, Wessels LF, Loo C, et al.Changes in gene expression associated with response to neoadjuvant chemotherapy in breast cancer. J Clin Oncol 2005;23(15):3331-3342.
-
Hannemann 2005 Hannemann J, Oosterkamp HM, Bosch CA, Velds A, Wessels LF, Loo C, et al.Changes in gene expression associated with response to neoadjuvant chemotherapy in breast cancer. J Clin Oncol 2005;23(15):3331-3342.
-
-
-
-
53
-
-
0017345746
-
-
Hayward 1977 Hayward JL, Carbone PP, Heuson JC, Kumaoka S, Segaloff A, Rubens RD. Assessment of response to therapy in advanced breast cancer: a project of the Programme on Clinical Oncology of the International Union Against Cancer, Geneva, Switzerland. Cancer 1977;39(3):1289- 1294.
-
Hayward 1977 Hayward JL, Carbone PP, Heuson JC, Kumaoka S, Segaloff A, Rubens RD. Assessment of response to therapy in advanced breast cancer: a project of the Programme on Clinical Oncology of the International Union Against Cancer, Geneva, Switzerland. Cancer 1977;39(3):1289- 1294.
-
-
-
-
54
-
-
0037098199
-
-
Higgins 2002 Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539-1558.
-
Higgins 2002 Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539-1558.
-
-
-
-
55
-
-
0020673660
-
-
Hortobagyi 1983 Hortobagyi GN, Blumenschein GR, Spanos W, Montague ED, Buzdar AU, Yap HY, et al.Multimodal treatment of locoregionally advanced breast cancer. Cancer 1983;51(5):763-8.
-
Hortobagyi 1983 Hortobagyi GN, Blumenschein GR, Spanos W, Montague ED, Buzdar AU, Yap HY, et al.Multimodal treatment of locoregionally advanced breast cancer. Cancer 1983;51(5):763-8.
-
-
-
-
56
-
-
0024263357
-
-
Hortobagyi 1988 Hortobagyi GN, Ames FC, Buzdar AU, Kau SW, McNeese MD, Paulus D, et al.Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy. Cancer 1988;62(12): 2507-16.
-
Hortobagyi 1988 Hortobagyi GN, Ames FC, Buzdar AU, Kau SW, McNeese MD, Paulus D, et al.Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy. Cancer 1988;62(12): 2507-16.
-
-
-
-
57
-
-
44949175148
-
-
Hortobagyi 1997 Hortobagyi GN, Buzdar AU. Locally advanced breast cancer. In: BonadonnaG, HortobagyiGN, GianniAM editor(s). Textbook of Breast Cancer: A Clinical Guide to Therapy. London, UK: Martin Dunitz Ltd, 1997:155-68.
-
Hortobagyi 1997 Hortobagyi GN, Buzdar AU. Locally advanced breast cancer. In: BonadonnaG, HortobagyiGN, GianniAM editor(s). Textbook of Breast Cancer: A Clinical Guide to Therapy. London, UK: Martin Dunitz Ltd, 1997:155-68.
-
-
-
-
58
-
-
0024794171
-
-
Jacquillat 1989 Jacquillat C, Weil M, Auclerc G, Auclerc MF, Khayat D, Baillet F. Neoadjuvant chemotherapy in the conservative management of breast cancer: a study of 252 patients. Recent Results in Cancer Research 1989;115:36-42.
-
Jacquillat 1989 Jacquillat C, Weil M, Auclerc G, Auclerc MF, Khayat D, Baillet F. Neoadjuvant chemotherapy in the conservative management of breast cancer: a study of 252 patients. Recent Results in Cancer Research 1989;115:36-42.
-
-
-
-
59
-
-
0038013982
-
-
Kaufmann 2003 Kaufmann M, von Minckwitz G, Smith R, Valero V, Gianni L, Eiermann W, et al.International expert panel on the use of primary (preoperative) systemic treatment of operable breast cancer: review and recommendations. Journal of Clinical Oncology 2003;21(13):2600-8.
-
Kaufmann 2003 Kaufmann M, von Minckwitz G, Smith R, Valero V, Gianni L, Eiermann W, et al.International expert panel on the use of primary (preoperative) systemic treatment of operable breast cancer: review and recommendations. Journal of Clinical Oncology 2003;21(13):2600-8.
-
-
-
-
60
-
-
0025777414
-
-
Kiebert 1991 Kiebert GM, de Haes JC, van de Velde CJ. The impact of breast-conserving treatment and mastectomy on the quality of life of early-stage breast cancer patients: a review. J Clin Oncol 1991;9(6):1059-1070.
-
Kiebert 1991 Kiebert GM, de Haes JC, van de Velde CJ. The impact of breast-conserving treatment and mastectomy on the quality of life of early-stage breast cancer patients: a review. J Clin Oncol 1991;9(6):1059-1070.
-
-
-
-
61
-
-
0031766681
-
-
Mansour 1998 Mansour EG, Gray R, Shatila AH, Tormey DC, Cooper MR, Osborne CK, et al.Survival advantage of adjuvant chemotherapy in high-risk node-negative breast cancer: Ten-year analysis - an intergroup study. Journal of Clinical Oncology 1998;16:3486-92.
-
Mansour 1998 Mansour EG, Gray R, Shatila AH, Tormey DC, Cooper MR, Osborne CK, et al.Survival advantage of adjuvant chemotherapy in high-risk node-negative breast cancer: Ten-year analysis - an intergroup study. Journal of Clinical Oncology 1998;16:3486-92.
-
-
-
-
62
-
-
3042837590
-
-
Molenaar 2004 Molenaar S, Oort F, Sprangers M, Rutgers E, Luiten E, Mulder J, et al.Predictors of patients' choices for breast-conserving therapy or mastectomy: a prospective study. Br J Cancer 2004;90(11):2123- 2130.
-
Molenaar 2004 Molenaar S, Oort F, Sprangers M, Rutgers E, Luiten E, Mulder J, et al.Predictors of patients' choices for breast-conserving therapy or mastectomy: a prospective study. Br J Cancer 2004;90(11):2123- 2130.
-
-
-
-
63
-
-
0032583387
-
-
Parmar 1998 Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Statistics in Medicine 1998;17(24):2815-34.
-
Parmar 1998 Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Statistics in Medicine 1998;17(24):2815-34.
-
-
-
-
64
-
-
85127138141
-
-
Pavic 2004 Pavic D, Koomen MA, Kuzmiak CM, Lee YH, Pisano ED. The role of magnetic resonance imaging in diagnosis and management of breast cancer. Technol Cancer Res Treat 2004;3(6):527-541.
-
Pavic 2004 Pavic D, Koomen MA, Kuzmiak CM, Lee YH, Pisano ED. The role of magnetic resonance imaging in diagnosis and management of breast cancer. Technol Cancer Res Treat 2004;3(6):527-541.
-
-
-
-
65
-
-
0019943660
-
-
Perloff 1982 Perloff M, Lesnick GJ. Chemotherapy before and after mastectomy in stage III breast cancer. Archives of surgery 1982;117:879-81.
-
Perloff 1982 Perloff M, Lesnick GJ. Chemotherapy before and after mastectomy in stage III breast cancer. Archives of surgery 1982;117:879-81.
-
-
-
-
66
-
-
0042071601
-
-
Poggi 2003 Poggi MM, Danforth DN, Sciuto LC, Smith SL, Steinberg SM, Liewehr DJ, et al.Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute Randomized Trial. Cancer 2003;98(4):697-702.
-
Poggi 2003 Poggi MM, Danforth DN, Sciuto LC, Smith SL, Steinberg SM, Liewehr DJ, et al.Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute Randomized Trial. Cancer 2003;98(4):697-702.
-
-
-
-
67
-
-
0020622326
-
-
Schick 1983 Schick P, Goodstein J, Moor J, Butler J, Senter KL. Preoperative chemotherapy followed by mastectomy for locally advanced breast cancer. Journal of Surgical Oncology 1983;22(4):278-82.
-
Schick 1983 Schick P, Goodstein J, Moor J, Butler J, Senter KL. Preoperative chemotherapy followed by mastectomy for locally advanced breast cancer. Journal of Surgical Oncology 1983;22(4):278-82.
-
-
-
-
68
-
-
0023754038
-
-
Segel 1988 Segel MC, Paulus DD, Hortobagyi GN. Advanced primary breast cancer: assessment at mammography of response to induction chemotherapy. Radiology 1988;169(1):49-54.
-
Segel 1988 Segel MC, Paulus DD, Hortobagyi GN. Advanced primary breast cancer: assessment at mammography of response to induction chemotherapy. Radiology 1988;169(1):49-54.
-
-
-
-
69
-
-
0029759604
-
-
Sharkey 1996 Sharkey FE, Addington SL, Fowler LJ, Page CP, Cruz AB. Effects of preoperative chemotherapy on the morphology of resectable breast carcinoma. Mod Pathol 1996;9(9):893-900.
-
Sharkey 1996 Sharkey FE, Addington SL, Fowler LJ, Page CP, Cruz AB. Effects of preoperative chemotherapy on the morphology of resectable breast carcinoma. Mod Pathol 1996;9(9):893-900.
-
-
-
-
70
-
-
24644490871
-
-
Smith 2005 Smith IE, Dowsett M, Ebbs SR, Dixon JM, Skene A, Blohmer JU, et al.Neoadjuvant treatment of postmenopausal breast cancer with anastrozole, tamoxifen, or both in combination: the Immediate Preoperative Anastrozole, Tamoxifen, or Combined with Tamoxifen (IMPACT) multicenter double-blind randomized trial. J Clin Oncol 2005;23(22):5108-5116.
-
Smith 2005 Smith IE, Dowsett M, Ebbs SR, Dixon JM, Skene A, Blohmer JU, et al.Neoadjuvant treatment of postmenopausal breast cancer with anastrozole, tamoxifen, or both in combination: the Immediate Preoperative Anastrozole, Tamoxifen, or Combined with Tamoxifen (IMPACT) multicenter double-blind randomized trial. J Clin Oncol 2005;23(22):5108-5116.
-
-
-
-
71
-
-
0034594628
-
-
Therasse 2000 Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, et al.New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000;92:205-216.
-
Therasse 2000 Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, et al.New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000;92:205-216.
-
-
-
-
72
-
-
0142091576
-
-
van der Hage 2003 van der Hage JA, Putter H, Bonnema J, Bartelink H, Therasse P, van de Velde CJ, EORTC Breast Cancer Group. Impact of locoregional treatment on the early-stage breast cancer patients: a retrospective analysis. Eur J Cancer 2003;39(15):2192-2199.
-
van der Hage 2003 van der Hage JA, Putter H, Bonnema J, Bartelink H, Therasse P, van de Velde CJ, EORTC Breast Cancer Group. Impact of locoregional treatment on the early-stage breast cancer patients: a retrospective analysis. Eur J Cancer 2003;39(15):2192-2199.
-
-
-
-
73
-
-
0034686622
-
-
van Dongen 2000 van Dongen JA. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European organization for research and treatment of cancer 10801 trial. J Natl Cancer Inst 2000;92(14):1143-1150.
-
van Dongen 2000 van Dongen JA. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European organization for research and treatment of cancer 10801 trial. J Natl Cancer Inst 2000;92(14):1143-1150.
-
-
-
-
74
-
-
0033034582
-
-
van Tienhoven 1999 van Tienhoven G, Voogd AC, Peterse JL, Nielsen M, Andersen KW, Mignolet, et al.Prognosis after treatment for loco-regional recurrence after mastectomy or breast conserving therapy in two randomised trials (EORTC10801 and DBCG-82TM). EORTC Breast Cancer Cooperative Group and the Danish Breast Cancer Cooperative Group. Eur J Cancer 1999;35(1):32-38.
-
van Tienhoven 1999 van Tienhoven G, Voogd AC, Peterse JL, Nielsen M, Andersen KW, Mignolet, et al.Prognosis after treatment for loco-regional recurrence after mastectomy or breast conserving therapy in two randomised trials (EORTC10801 and DBCG-82TM). EORTC Breast Cancer Cooperative Group and the Danish Breast Cancer Cooperative Group. Eur J Cancer 1999;35(1):32-38.
-
-
-
-
75
-
-
0028880066
-
-
Veronesi 1995 Veronesi U, Bonadonna G, Zurrida S, Galimberti V, Greco M, Brambilla C, et al.Conservation surgery after primary chemotherapy in large carcinomas of the breast. Ann Surg 1995;222(5):612-618.
-
Veronesi 1995 Veronesi U, Bonadonna G, Zurrida S, Galimberti V, Greco M, Brambilla C, et al.Conservation surgery after primary chemotherapy in large carcinomas of the breast. Ann Surg 1995;222(5):612-618.
-
-
-
-
76
-
-
0037126350
-
-
Veronesi 2002 Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, et al.Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. New England Journal of Medicine 2002;347(16):1227-1232.
-
Veronesi 2002 Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, et al.Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. New England Journal of Medicine 2002;347(16):1227-1232.
-
-
-
-
77
-
-
0030059891
-
-
Vinnicombe 1996 Vinnicombe SJ, MacVicar AD, Guy RL, Sloane JP, Powles TJ, Knee G, et al.Primary breast cancer: mammographic changes after neoadjuvant chemotherapy, with pathologic correlation. Radiology 1996;198(2):333-340.
-
Vinnicombe 1996 Vinnicombe SJ, MacVicar AD, Guy RL, Sloane JP, Powles TJ, Knee G, et al.Primary breast cancer: mammographic changes after neoadjuvant chemotherapy, with pathologic correlation. Radiology 1996;198(2):333-340.
-
-
-
-
78
-
-
27744526814
-
-
Voogd 2005 Voogd AC, van Oost FJ, Rutgers EJT, Elkhuizen PHM, van Geel AN, Scheijmans LJEE, et al.Long-term prognosis of patients with local recurrence after conservative surgery and radiotherapy for early breast cancer. European Journal of Cancer 2005;41(17):2637-2644.
-
Voogd 2005 Voogd AC, van Oost FJ, Rutgers EJT, Elkhuizen PHM, van Geel AN, Scheijmans LJEE, et al.Long-term prognosis of patients with local recurrence after conservative surgery and radiotherapy for early breast cancer. European Journal of Cancer 2005;41(17):2637-2644.
-
-
-
-
79
-
-
13844310310
-
-
Wang 2005 Wang Y, Klijn JG, Zhang Y, Sieuwerts AM, Look MP, Yang F, et al.Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 2005;365(9460): 671-679.
-
Wang 2005 Wang Y, Klijn JG, Zhang Y, Sieuwerts AM, Look MP, Yang F, et al.Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 2005;365(9460): 671-679.
-
-
-
-
80
-
-
0034063101
-
-
Whelan 2000 Whelan TJ, Julian J, Wright J, Jadad AR, Levine ML. Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis. Journal of Clinical Oncology 2000;18(6):1220-1229.
-
Whelan 2000 Whelan TJ, Julian J, Wright J, Jadad AR, Levine ML. Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis. Journal of Clinical Oncology 2000;18(6):1220-1229.
-
-
-
-
81
-
-
0034035650
-
-
Wolff 2000 Wolff AC, Davidson NE. Primary systemic therapy in operable breast cancer. J Clin Oncol 2000;18(7):1558-1569.
-
Wolff 2000 Wolff AC, Davidson NE. Primary systemic therapy in operable breast cancer. J Clin Oncol 2000;18(7):1558-1569.
-
-
-
-
82
-
-
33646493702
-
-
Xing 2006 Xing Y, Foy M, Cox DD, Kuerer HM, Hunt KK, Cormier JN. Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer. Br J Surg 2006;93(5):539-546.
-
Xing 2006 Xing Y, Foy M, Cox DD, Kuerer HM, Hunt KK, Cormier JN. Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer. Br J Surg 2006;93(5):539-546.
-
-
-
-
83
-
-
0021909115
-
-
Yusuf 1985 Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Progress in Cardiovascular Diseases 1985;27:335-371.
-
Yusuf 1985 Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Progress in Cardiovascular Diseases 1985;27:335-371.
-
-
-
|